The Power Of Small: Nanoplasmid™ Vector Platform

With gene therapy advancing at a record pace, we recognize the enormous promise your work can bring to therapeutics. Traditional plasmid technology was introduced over 40 years ago. Most conventional plasmids on the market contain a large backbone with typically 2000 or more base pairs. This extraneous amount of DNA can hinder plasmid performance, and bring challenges in manufacturing and safety risks.

We are proud to deliver a superior, modern plasmid technology to your therapeutic endeavors. Small in size, big in advantages, our Nanoplasmid™ Vector platform is quite possibly our smallest breatkthrough yet.